Highbridge Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-14,055
Closed -$2.68M 563
2018
Q3
$2.68M Buy
+14,055
New +$2.58M 0.06% 300
2018
Q1
Sell
-97,691
Closed -$16.4M 1908
2017
Q4
$16M Sell
97,691
-114,390
-54% -$20.5M 0.29% 79
2017
Q3
$43.5M Buy
212,081
+192,081
+960% +$44.7M 0.65% 22
2017
Q2
$4.86M Buy
+20,000
New +$4.7M 0.07% 303
2017
Q1
Sell
-25,000
Closed -$5.25M 1838
2016
Q4
$5.25M Sell
25,000
-10,543
-30% -$2.18M 0.09% 240
2016
Q3
$8.19M Buy
+35,543
New +$8.69M 0.13% 182
2016
Q2
Sell
-26,614
Closed -$7.13M 1904
2016
Q1
$7.13M Buy
26,614
+8,776
+49% +$2.51M 0.12% 205
2015
Q4
$5.58M Sell
17,838
-29,916
-63% -$8.91M 0.09% 265
2015
Q3
$13M Sell
47,754
-24,620
-34% -$7.56M 0.2% 139
2015
Q2
$22M Sell
72,374
-16,427
-18% -$4.9M 0.28% 95
2015
Q1
$26.4M Buy
+88,801
New +$25.3M 0.36% 76
2014
Q4
Sell
-41,844
Closed -$10.5M 1535
2014
Q3
$10.1M Buy
+41,844
New +$9.36M 0.13% 198
2014
Q2
Sell
-3,106
Closed -$643K 1361
2014
Q1
$639K Buy
+3,106
New +$615K 0.01% 644
2013
Q4
Sell
-24,830
Closed -$3.88M 1424
2013
Q3
$3.58M Sell
24,830
-122,036
-83% -$16.3M 0.04% 393
2013
Q2
$18.5M Buy
+146,866
New +$16.6M 0.18% 140

Other funds holding AGN

Highbridge Capital Management's AGN Position: Q4 2018 in Review

Highbridge Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 14,055 shares — an estimated $2.68M sold.

Highbridge Capital Management first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $43.5M in Q3 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Highbridge Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 14,055 Allergan plc shares in Q4 2018, an estimated $2.68M.
  • Highbridge Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • Highbridge Capital Management's Allergan plc position peaked at $43.5M in Q3 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.